PLoS ONE (Jan 2015)

F3MB(PANDER) decreases mice hepatic triglyceride and is associated with decreased DGAT1 expression.

  • Xiaoqing Mo,
  • Chijiao Yang,
  • Xuelan Wang,
  • Brant R Burkhardt,
  • Yangbin Li,
  • Haipeng Xia,
  • Xiaopei Cao

DOI
https://doi.org/10.1371/journal.pone.0117156
Journal volume & issue
Vol. 10, no. 2
p. e0117156

Abstract

Read online

ObjectivePancreatic-derived factor (PANDER, also named as FAM3B) is secreted by pancreatic α and β cells. Increasing evidence suggests that it may serve a hormonal function related to glycemic and lipid metabolism. In this study, we investigated the effects of PANDER overexpression on hepatic and adipose triglyceride metabolism in high-fat diet-fed male C57BL/6 mice.MethodsPANDER overexpression was achieved by tail-vein injection of recombinant Ad-PANDER and Ad-GFP injected mice served as a control. The TG metabolism in both groups were compared.ResultsAdenoviral-mediated overexpression of PANDER did not affect body weight, food consumption, or liver enzymes. The triglyceride (TG) content of both liver and adipose tissue was significantly decreased in Ad-PANDER mice (liver: 6.16±1.89 mg/g vs. control 14.95±2.27 mg/g, PConclusionOverexpression of PANDER is associated with observable decreases in TG, increases in PKA phosphorylation, and decreased DGAT1 expression, suggesting a possible interrelationship. The mechanisms by which this occurs remain to be elucidated.